These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1119113)

  • 21. [Complex formation of heparin with the inhibitor of non-enzymatic fibrinolysis isolated from the spleen].
    Liapina LA; Ammosova IaM
    Vopr Med Khim; 1987; 33(3):88-91. PubMed ID: 3630024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
    Kudriashov BA; Pastorova VE; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Dec; 72(12):1653-8. PubMed ID: 3817209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Restriction of epinephrine-heparin and fibrinogen-heparin complex formation under stress conditions in the blood of animals maintained on an atherogenic diet].
    Kudriashov BA; Bazaz'ian GG; Liapina LA; Sytina NP
    Kardiologiia; 1971 Oct; 11(10):58-65. PubMed ID: 5138046
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of an adrenaline-heparin complex on blood lipolytic activity in animals during normal and depressed states of the anticoagulation system].
    Bazaz'ian GG; Liapina LA; Mendelevich OA
    Vopr Med Khim; 1974; 20(5):476-82. PubMed ID: 4456797
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heparin-adrenaline complex as a humoral agent of the anticoagulation system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1971; 17(1):46-53. PubMed ID: 5555145
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Formation of noradrenaline-heparin and adrenaline-heparin complexes in the blood of young people under emotional and intellectual stress].
    Kudriashov BA; Podol'skaia OV; Liapina LA
    Vopr Med Khim; 1972; 18(4):385-90. PubMed ID: 4661843
    [No Abstract]   [Full Text] [Related]  

  • 29. [Method for the determination of the action of physiologic solvents of nonstabilized fibrin].
    Kudriashov BA; Liapina LA
    Lab Delo; 1971; 6():326-9. PubMed ID: 4108741
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiologic properties of heparin--thromboplastin complex].
    Kudriashov BA; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1978 Jun; 64(6):771-6. PubMed ID: 680264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anticoagulant and nonenzymatic fibrinolytic activity of plasma in animals after intravenous injection of a heparin-antithrombin III complex].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biull Eksp Biol Med; 1985 Jan; 99(1):62-4. PubMed ID: 3967074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Formation of a heparin-prothrombin complex].
    Liapina LA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1979; 25(1):41-6. PubMed ID: 425371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the activity of thrombocytic factors of coagulation in hypercoagulation induced by the administration of adrenaline].
    Markosian AA; Ladynina EA
    Probl Gematol Pereliv Krovi; 1975 Jun; 20(6):30-2. PubMed ID: 1135186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 35. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin-heparin complex, its physiological properties].
    Kudriashov BA; Pytel' IuA; Liapina LA; Baskakova GM
    Vopr Med Khim; 1981; 27(4):547-52. PubMed ID: 7027617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin].
    Kudriashov BA; Liapina LA; Molchanova LV; Rustamova BA
    Vopr Med Khim; 1970; 16(2):161-8. PubMed ID: 4247358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.